These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1288224)

  • 1. [Clinical significance of stereological estimation of mean nuclear volume in human bladder carcinoma--further analysis of nuclear morphometric variables].
    Fukuzawa S; Hashimura T; Horii Y; Yoshida O; Sasaki M
    Hinyokika Kiyo; 1992 Dec; 38(12):1361-8. PubMed ID: 1288224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of the stereological estimation of mean nuclear volume in human bladder carcinoma--relation to tumor grade, stage and prognosis].
    Fukuzawa S; Hashimura T; Horii Y; Yoshida O; Sasaki M; Yamabe H
    Hinyokika Kiyo; 1992 Jan; 38(1):25-9. PubMed ID: 1546565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear morphometry for improved prediction of the prognosis of human bladder carcinoma.
    Fukuzawa S; Hashimura T; Sasaki M; Yamabe H; Yoshida O
    Cancer; 1995 Nov; 76(10):1790-6. PubMed ID: 8625049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of nuclear morphometry as predictive factor of progression in bladder papillary carcinoma].
    García I; Alvarez M; Hierro I; Vicioso L; Hidalgo R; Matilla A
    Actas Urol Esp; 1994; 18(10):937-41. PubMed ID: 7856480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    J Urol; 2000 Aug; 164(2):352-5. PubMed ID: 10893583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of nuclear area index in patients with bladder cancer.
    Yusup A; Kanamaru H; Aoki Y; Saikawa S; Moriyama N; Oyama N; Akino H; Okada K; Yokoyama O
    Int J Urol; 2004 Jun; 11(6):374-8. PubMed ID: 15157205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma.
    Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M
    Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stereological estimation of mean nuclear volume in bladder cancer--measurement by point sampled intercepts].
    Sasaki M; Kaneko Y
    Hinyokika Kiyo; 1990 Aug; 36(8):909-12; discussion 912-3. PubMed ID: 2239591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometry in human transitional cell bladder cancer. Nuclear area and standard deviation of nuclear area--relation to tumor grade (WHO) and prognosis.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M
    Eur Urol; 1990; 17(2):155-60. PubMed ID: 2311640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment.
    Brugghe J; Baak JP; Wiltshaw E; Brinkhuis M; Meijer GA; Fisher C
    Gynecol Oncol; 1998 Jan; 68(1):47-53. PubMed ID: 9454660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of nuclear volume of nontumorous bladder mucosa in patients with bladder tumor--measurement by vertical section].
    Sasaki M; Nakamura E; Kaneko Y
    Hinyokika Kiyo; 1991 Jul; 37(7):679-84. PubMed ID: 1927766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prognostic value of mean nuclear area and mean nuclear volume in bladder cancer].
    Iguchi A; Hirata Y; Ichigi Y; Masaki Z
    Nihon Hinyokika Gakkai Zasshi; 1994 Oct; 85(10):1552-7. PubMed ID: 7990304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphometric study of transitional carcinoma of the bladder (I): analysis of 148 superficial tumors].
    Portillo Martín JA; Val Bernal F; Garijo Ayenza F; Buelta Carrillo L; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Goméz MA; Fernández Gómez JM; Concepción Masip T
    Arch Esp Urol; 1991 Apr; 44(3):243-9. PubMed ID: 1867504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphometric study of transitional carcinoma of the bladder (II): analysis of 95 infiltrating tumors].
    Portillo Martín JA; Val Bernal F; Garijo Ayenza F; Buelta Carrillo L; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Gómez MA; Concepción Masip T; Fernández Gómez JM
    Arch Esp Urol; 1991 Apr; 44(3):251-6. PubMed ID: 1867505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
    Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C
    J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical prognostic factors in superficial cancer of the urinary bladder].
    Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
    Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
    Ogura K; Fukuzawa S; Habuchi T; Ogawa O; Yoshida O
    Int J Urol; 1997 Nov; 4(6):561-6. PubMed ID: 9477184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.